JPH02142720A - Perfume - Google Patents
PerfumeInfo
- Publication number
- JPH02142720A JPH02142720A JP29797488A JP29797488A JPH02142720A JP H02142720 A JPH02142720 A JP H02142720A JP 29797488 A JP29797488 A JP 29797488A JP 29797488 A JP29797488 A JP 29797488A JP H02142720 A JPH02142720 A JP H02142720A
- Authority
- JP
- Japan
- Prior art keywords
- effect
- perfume
- camphor
- results
- effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002304 perfume Substances 0.000 title abstract description 8
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 6
- FACFHHMQICTXFZ-UHFFFAOYSA-N 2-(2-phenylimidazo[1,2-a]pyridin-3-yl)ethanamine Chemical compound N1=C2C=CC=CN2C(CCN)=C1C1=CC=CC=C1 FACFHHMQICTXFZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 6
- FKUPPRZPSYCDRS-UHFFFAOYSA-N Cyclopentadecanolide Chemical compound O=C1CCCCCCCCCCCCCCO1 FKUPPRZPSYCDRS-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229930008380 camphor Natural products 0.000 claims abstract description 6
- 229960000846 camphor Drugs 0.000 claims abstract description 6
- 229940067137 musk ketone Drugs 0.000 claims abstract description 6
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 5
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 5
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940116229 borneol Drugs 0.000 claims abstract description 5
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 5
- 230000000694 effects Effects 0.000 claims description 23
- 239000003205 fragrance Substances 0.000 claims description 13
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 5
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims description 5
- 229960005233 cineole Drugs 0.000 claims description 5
- 230000013632 homeostatic process Effects 0.000 abstract description 5
- 230000001624 sedative effect Effects 0.000 abstract description 4
- 230000008859 change Effects 0.000 abstract description 3
- 238000012423 maintenance Methods 0.000 abstract description 2
- 230000037007 arousal Effects 0.000 abstract 2
- 230000003044 adaptive effect Effects 0.000 abstract 1
- -1 etc. Chemical compound 0.000 abstract 1
- 238000005259 measurement Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000011514 reflex Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- ORMHZBNNECIKOH-UHFFFAOYSA-N 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde Chemical compound CC(C)(O)CCCC1=CCC(C=O)CC1 ORMHZBNNECIKOH-UHFFFAOYSA-N 0.000 description 2
- 241000402754 Erythranthe moschata Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- SUAUILGSCPYJCS-UHFFFAOYSA-N Musk ambrette Chemical compound COC1=C([N+]([O-])=O)C(C)=C([N+]([O-])=O)C=C1C(C)(C)C SUAUILGSCPYJCS-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 2
- 229940007550 benzyl acetate Drugs 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229940116411 terpineol Drugs 0.000 description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- VPKMGDRERYMTJX-CMDGGOBGSA-N 1-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-1-penten-3-one Chemical compound CCC(=O)\C=C\C1C(C)=CCCC1(C)C VPKMGDRERYMTJX-CMDGGOBGSA-N 0.000 description 1
- RCSBILYQLVXLJG-UHFFFAOYSA-N 2-Propenyl hexanoate Chemical compound CCCCCC(=O)OCC=C RCSBILYQLVXLJG-UHFFFAOYSA-N 0.000 description 1
- JRJBVWJSTHECJK-PKNBQFBNSA-N 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one Chemical compound CC(=O)C(\C)=C\C1C(C)=CCCC1(C)C JRJBVWJSTHECJK-PKNBQFBNSA-N 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DUKPKQFHJQGTGU-UHFFFAOYSA-N Hexyl salicylic acid Chemical compound CCCCCCOC(=O)C1=CC=CC=C1O DUKPKQFHJQGTGU-UHFFFAOYSA-N 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 206010027940 Mood altered Diseases 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002386 air freshener Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 239000010627 cedar oil Substances 0.000 description 1
- 229930015336 cedren Natural products 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 150000002499 ionone derivatives Chemical class 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 230000007510 mood change Effects 0.000 description 1
- KJONHKAYOJNZEC-UHFFFAOYSA-N nitrazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1 KJONHKAYOJNZEC-UHFFFAOYSA-N 0.000 description 1
- 229960001454 nitrazepam Drugs 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 230000002165 photosensitisation Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 239000001738 pogostemon cablin oil Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004800 psychological effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000010671 sandalwood oil Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、目覚め効果又はやすらぎ効果を有する香料に
関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a fragrance having a wake-up effect or a soothing effect.
更に詳しくは、現代人に求められる環境への即応を生理
心理学的見地から援助する目的に関するものである。
現代人、特に組織内にて就業する人々は刻々変化する状
況に対応することをせまられている。その変化に対応す
る行動を遅延なくとるためには、非常に大きな努力を必
要とする。More specifically, it is related to the purpose of helping modern people respond quickly to the environment from a physiological and psychological standpoint.
Modern people, especially those working within organizations, are forced to respond to ever-changing situations. In order to take action to respond to these changes without delay, a tremendous amount of effort is required.
本発明は、現代人の生理心理学的恒常性の維持機能を向
上させる目的で使用される。The present invention is used for the purpose of improving the physiological and psychological homeostasis maintenance function of modern humans.
例えば、長時間にわたる自動車の運転中に生じる倦怠感
や気分的な疲労感をなくするなどの、状況変化への適応
能力の強化または補助的な目的で目覚めた状態とする必
要がある場合がある。また、現代社会は科学技術の急速
な発展に伴い生活にも急速な変動をもたらしてている。For example, it may be necessary to be awake for the purpose of strengthening the ability to adapt to changes in circumstances or for auxiliary purposes, such as eliminating fatigue and emotional fatigue that occur while driving a car for long periods of time. . Furthermore, modern society is bringing about rapid changes in daily life due to the rapid development of science and technology.
5elye、Hによれば、刺激により生じる非特異反
応としてのストレスは個人のみならず人類の進歩に必要
不可欠な要素であり、生きることがすなわちストレスで
あるとしている。したがって、ストレスを生きることに
必要な刺激剤として利用していく上で、生理心理的恒常
性の維持は必要不可欠であり、ストレスにより生じる中
枢神経を主とした複雑な神経系の励起状態からやすらぎ
の状態にし、恒常性の維持を向上させる必要がある。
本発明は、この目的のために使用され、室内芳香剤をは
じめ、香料や石鹸等の化粧料に配合される。According to Elye and H., stress, which is a non-specific reaction caused by stimulation, is an essential element not only for individuals but also for the progress of humanity, and that living is, in other words, stress. Therefore, in order to utilize stress as a stimulant necessary for life, it is essential to maintain physiological and psychological homeostasis. It is necessary to maintain this state and improve homeostasis.
The present invention is used for this purpose and is incorporated into cosmetics such as room air fresheners, perfumes, and soaps.
従来芳香剤の有用性として抗炎症効果や防腐効果、食欲
の抑制・亢進効果が報告されている。Anti-inflammatory effects, antiseptic effects, and appetite suppressing and enhancing effects have been reported to be useful for aromatic agents.
一部に中枢神経系への作用の報告があるが、単なる主観
的なSD法による結果に基づくものもあり、主観的な嗜
好性の影響があり科学的な根拠が低かった。 また特開
昭61−267526号公報には“ストレスに対する生
理的及び、又は主観的反応を減少させる方法”が開示さ
れている。 この発明は血圧とムードの変化を測定し、
天然精油の有用性について言及している。 また、モノ
テルペンを主とした植物精油を配合した香料により疲労
軽減、視覚機能維持効果を付与した商品がある。Although there are some reports of effects on the central nervous system, some are based on merely subjective results of the SD method, and there is a lack of scientific basis due to the influence of subjective preference. Furthermore, Japanese Patent Application Laid-Open No. 61-267526 discloses a "method for reducing physiological and/or subjective reactions to stress." This invention measures blood pressure and mood changes,
It mentions the usefulness of natural essential oils. Additionally, there are products that use fragrances containing plant essential oils, mainly monoterpenes, to reduce fatigue and maintain visual function.
従来の技術は主観的な嗜好性の影響が試験結果に大きな
影響を与え、従って個人差が大きく科学的な根拠を欠い
ていた。 また、前述の特開昭61267526号公報
も主観的な部分が含まれていること及び血圧等のストレ
スに対する2次的生理反応を測定していることから、不
確定な要素が大きく安定した効果が得られていなかった
。In conventional techniques, test results were largely influenced by subjective preference, and therefore had large individual differences and lacked scientific basis. In addition, the above-mentioned Japanese Patent Application Laid-Open No. 61267526 also contains subjective parts and measures secondary physiological responses to stress such as blood pressure, so there are large uncertainties and stable effects cannot be expected. I wasn't getting it.
また、天然精油を試料に用いているため、その特性とし
て成分が産地や採取時期・年代により微妙に異なること
が一般に知られている。 従って、それらの効果も非常
に不安定である。Furthermore, since natural essential oils are used as samples, it is generally known that their properties differ slightly depending on the region of production, time of collection, and age. Therefore, their effects are also very unstable.
上記従来の技術の持つ問題点を解決するため、化学構造
が明確な多くの高純度の単品香料原料を調査した。 そ
の構造の明確な原料を配合した香料の目覚め効果又はや
すらぎ効果を検討した結果、ムスクケトン、シクロペン
タデカノリド (以後CPD)、8−α512−オキ
シド−13,14,15゜16−テトラノルバン(以後
0TN)に顕著な目覚め効果を、ユーカリプトール、
カンファー、ボルネオールに顕著なやすらぎ効果を認め
た。In order to solve the problems of the above-mentioned conventional techniques, we investigated a number of high-purity single fragrance raw materials with clear chemical structures. As a result of examining the awakening or soothing effects of fragrances containing raw materials with clear structures, we found musk ketone, cyclopentadecanolide (hereinafter referred to as CPD), 8-α512-oxide-13,14,15°16-tetranorban (hereinafter referred to as 0TN) has a remarkable awakening effect, eucalyptol,
A remarkable soothing effect was observed in camphor and borneol.
ムスクアンブレットにも目覚め効果があることを発見し
たが、ムスクアンブレットには、光感作性があり、安全
性に問題があるため、本発明には使用しなかった。Although it was discovered that musk ambrette also has a wake-up effect, it was not used in the present invention because musk ambrette has photosensitizing properties and has safety issues.
目覚め効果を客観的に測定する方法として、意識水準に
よって極めて敏感に変動する脳波の波形の解析が実施さ
れる。 いわゆる、脳波のα波、β波が意識水準により
変動するのであるが、香料の影響を調査する過程におい
て、香料への興味により精神活動の高揚に付随して意識
水準が高まり、α波がβ波へ移行する現象が認められる
。As a method to objectively measure the awakening effect, analysis of brain wave waveforms, which vary extremely sensitively depending on the level of consciousness, is carried out. The so-called alpha and beta brain waves fluctuate depending on the level of consciousness, but in the process of investigating the effects of fragrances, the level of consciousness increases as mental activity increases due to interest in fragrances, and alpha waves change to beta waves. A phenomenon of transition to waves is observed.
従って、いわゆる脳波の測定では香料の特異的な心理効
果を測定できない。 ところが、意識水準の高い時に生
じる脳の電気信号に対する影響は一定の条件下での反応
であり、上記の欠点を排除でき、有効な手段となる。Therefore, so-called brain wave measurements cannot measure the specific psychological effects of fragrances. However, the influence on the electrical signals of the brain that occurs when the level of consciousness is high is a reaction under certain conditions, and the above drawbacks can be eliminated, making it an effective means.
今回の検討には、音声刺激により引き起こされる前頭部
の随伴性陰性変動(qontigent negati
vevariation−以下 CNV)と呼ばれる陰
性のゆっくりした電位の変化が測定に用いられた。In this study, we investigated the qontient negative fluctuations in the frontal region caused by voice stimulation.
A slow negative potential change called vevariation (CNV) was used for the measurements.
詳細な実験方法を記す。 警告刺激音から2秒後に運動
の開始を意味する光信号が続き、光を認識したことを表
現するボタン押しの運動反応が要求される。 この一連
の繰り返しの中で、警告刺激の前に試料が与えられ、2
回の命令による呼吸の後、最後の3回目の吸息に合わせ
て被験者の鼻孔近くの容器から香りの状態で投与された
。 CNV測定のための電極は前頭部にはり着けられ、
耳朶との間の電位記録が測定され、また手掌と前腕層側
部位につけられた電極間における皮膚電位水準の変動が
測定された。Detailed experimental methods are described. Two seconds after the warning stimulus sound, a light signal indicating the start of movement follows, and a motor response of a button press is required to express recognition of the light. In this series of repetitions, a sample is given before the warning stimulus, and 2
After three commanded breaths, the scent was administered from a container near the subject's nostrils during the third and final inhalation. Electrodes for CNV measurement were attached to the forehead,
Electric potential was recorded between the earlobe and changes in skin potential level between electrodes attached to the palm and forearm.
覚醒効果を示すカフェインを投与した場合、CNVの振
幅が増大し、鎮静効果を示すニトラゼパムを投与した場
合にはCNVの振幅は減少することがH,Ashton
らにより報告されている。H, Ashton found that when caffeine, which has a stimulant effect, is administered, the CNV amplitude increases, and when nitrazepam, which has a sedative effect, is administered, the CNV amplitude decreases.
It has been reported by et al.
これらの変動は警告刺激後500〜1000 m5ec
の初期成分に顕著に現れる。 表−1に単一化学物質と
実施例とのCNV測定結果を示した。 この効果性は上
記初期成分の最大振幅値で表現されている。These fluctuations range from 500 to 1000 m5ec after the warning stimulus.
It appears prominently in the initial components of. Table 1 shows the CNV measurement results for single chemical substances and Examples. This effectiveness is expressed by the maximum amplitude value of the initial component.
表−1の結果に認められるように、ムスク系の香料に目
覚め効果が顕著である。 ムスクケトンは無賦香対照と
の平均値の差の検定において有意水準1%で差が認めら
れ、CPD及びOTNは、5%で有意差があった。 こ
れら化学物質は構造的に異なっており、カフェインのよ
うな中枢神経系への直接薬理学的作用による覚醒効果を
有しているとは考え難い。 おそらく、潜在意識におけ
るムスクとしての匂いの認知が興奮作用を有する物質の
遊離を促進させ、目覚め効果が発現するものであろうと
考えられる。As seen in the results in Table 1, musk fragrances have a remarkable awakening effect. In the test of the difference in mean value between musk ketone and the unscented control, a difference was observed at a significance level of 1%, and a significant difference was observed at 5% for CPD and OTN. These chemicals are structurally different and are unlikely to have stimulant effects due to direct pharmacological action on the central nervous system like caffeine. It is thought that subconscious recognition of the odor as a musk promotes the release of stimulant substances, resulting in the awakening effect.
一方、カンファー調の香料にやすらぎ効果が認められた
。 最もやすらぎ効果の高い化学物質は、ユーカリプト
ールの1%有意であり、カンファー及びボルネオールは
5%有意で鎮静効果が認められた。 ユーカリプトール
は、同時期に実施した皮膚電位水準(以下 5PL)測
定にても顕著な皮膚電位の低下を示し鎮静効果が裏付け
された。On the other hand, camphor-like fragrances were found to have a soothing effect. The chemical substance with the highest soothing effect was eucalyptol, with a significance of 1%, and camphor and borneol, which had a significant sedative effect with a significance of 5%. Measurements of eucalyptol's skin potential level (hereinafter referred to as 5PL) conducted at the same time also showed a significant decrease in skin potential, supporting its sedative effect.
表−2に上記単一化学物質にて目覚め効果のあった香料
を用いた香水(実施例1)の組成を示す。Table 2 shows the composition of a perfume (Example 1) using the above-mentioned single chemical substance that had a wake-up effect.
また、表−3には上記単一化学物質にてやすらぎ効果の
あった香料を用いた香水(実施例2)を示す。Furthermore, Table 3 shows a perfume (Example 2) using the above-mentioned single chemical substance having a soothing effect.
実施例1.実施例2および各実施例から有効成分を除去
し、替わりにエタノールを加えた試料を各々比較例1及
び比較例2としてCNVを測定した。 その結果を表−
4に示した。Example 1. Samples in which the active ingredient was removed from Example 2 and each Example and ethanol was added instead were used as Comparative Example 1 and Comparative Example 2, respectively, and CNV was measured. Table the results.
4.
T−ウンデカラクトン
オレンジオイルターペンレス
0.1
0.2
リナリルアセテート
4.0
ジャスミンベース
2.0
ベンジルアセテート
2.0
α−イソメチルイオノン
n−へキシルサリシレート
ムスクケトン
12.0
IOoo
10.0
CPD
OTN
レモンオイル
イランイランオイルエクストラ
ターピネオール
リナロール
フェニルエチルアルコール
ライラールLD
ベンジルアセテート
クローブオイル
サンダルウツドオイル
イオノン
シダーウッドオイル
20.0
ユーカリプトール
パチュリ−オイル
メチルイオノン
オイケノール
ライラールイC)
アセチルセドレン
パインオイル
10.0
14.0
シトロネロール
ターピネオール
リナロール
カンファー
ボルネオール
アリルカプロエート
レシノイドオリバノム
アブソリュートファーバルサム
タービニルプロピオネート
レジノイドスチランクス
実施例1及び実施例2の示すCNV値には、無賦香の対
照のCNV値と各々有意水準1%で有意の差(]2)
を認めたが、比較例1及び比較例2の示すCNV値には
有意差は認められなかった。T-undecalactone orange oil turpenless 0.1 0.2 linalyl acetate 4.0 jasmine base 2.0 benzyl acetate 2.0 α-isomethylionone n-hexyl salicylate musk ketone 12.0 IOoo 10.0 CPD OTN Lemon Oil Ylang Ylang Oil Extra Terpineol Linalool Phenylethyl Alcohol Lyral LD Benzyl Acetate Clove Oil Sandal Wood Oil Ionone Cedarwood Oil 20.0 Eucalyptol Patchouli Oil Methyl Ionone Eukenol Lyral Rui C) Acetyl Cedren Pine Oil 10.0 14.0 Citronellol Terpineol Linalool Camphor Borneol Allyl Caproate Resinoid Olivanom Absolute Fur Balsam Turvinyl Propionate Resinoid Styranx However, no significant difference was observed between the CNV values of Comparative Example 1 and Comparative Example 2.
次いで、実施例の生理心理学的な総合評価を調査した。Next, the physiological and psychological comprehensive evaluations of the examples were investigated.
その試験方法を以下に示した。The test method is shown below.
男女それぞれ5名を防音装置を施した恒温恒湿無臭室に
て、皮膚電位水準(以下 5PL)の装置を接着し、入
室休養−時間後から反射速度を測定し目覚め状態及びや
すらぎ状態を調査した。A skin potential level (5PL) device was attached to five male and female subjects in a constant temperature, constant humidity, and odorless room equipped with a soundproof device, and their reflex speed was measured after a period of rest in the room to investigate their wakefulness and restfulness. .
反射速度はコンピューター画面に表示された2つの矢印
が接合する瞬間を判断し、ボタンを押す。The reflex speed is determined by determining the moment when two arrows displayed on the computer screen join, and then pressing a button.
その設定された接合点とボタンを押した時点とのずれを
10回測定し、平均値を求めるものである。 以下この
方法をRNMとする。 入室−時間後に対照として、無
賦香にて誤差距離を測定し、ついで実施例および比較例
の調査を行った。 さらに順序効果を調査するために、
無賦香の状態で休養時間を一時間与え、対照としての測
定を実施し、先と異なる順序にて試料を与えた。 試料
の濃度はあらかじめ調査された不快感を与えない最高濃
度に設定された。 表−5にRNMの結果を6にSPL
の結果を示した。The deviation between the set junction point and the point at which the button is pressed is measured 10 times, and the average value is determined. Hereinafter, this method will be referred to as RNM. After entering the room, the error distance was measured as a control without fragrance, and then the Examples and Comparative Examples were investigated. To further investigate the order effect,
A resting period of one hour was given in the unscented state, and a control measurement was carried out, and the samples were given in a different order. The concentration of the sample was set to the highest concentration that did not cause discomfort, as determined in advance. Table 5 shows the results of RNM and SPL in 6.
The results were shown.
RNMの結果
表
SPLの結果
るため、それぞれの平均値で除し標準化した数値により
平均値の差の検定を行い、1%有意水準の被験者を著効
、5%有意の被験者を有効、10%有意の被験者をやや
有効、10%より大きい被験者を無効とし、カイ2乗法
にて検定した。 その結果を表−7に記載した。RNM result table In order to obtain the SPL results, the difference in the mean values was tested using the standardized value divided by each mean value, and the subjects with a 1% significance level were evaluated as significant, those with 5% significance as effective, and 10%. Tests were performed using the chi-square method, with subjects showing significant results as slightly valid and subjects with a value greater than 10% as invalid. The results are listed in Table-7.
反射能力の調査の結果は以下の方法にて評価した。 個
人差を考慮し、個人の試料間の差を求め試料の順序によ
る差および性別による差はみられなかったため、表−5
のサンプル数を10として処理した。 各々実施例と比
較例との間でカイ2乗検定を行った結果、有意水準1%
で目覚め効果又はやすらぎ効果が認められた。The results of the reflex ability survey were evaluated using the following method. Considering individual differences, we calculated the differences between individual samples and found no differences due to sample order or gender. Table 5.
The number of samples was set to 10. As a result of performing a chi-square test between each example and comparative example, the significance level was 1%.
An awakening effect or a relaxing effect was observed.
SPLの測定結果では、実施例1については通常状態で
発生する低下が認められず、目覚め効果を表わしており
、実施例2については顕著な低下が認められ、やすらぎ
効果が観察された。In the SPL measurement results, in Example 1, a decrease that occurs under normal conditions was not observed, indicating an awakening effect, and in Example 2, a significant decrease was observed, indicating a relaxing effect.
以上のように、本発明により、目覚め効果を有する香料
及びやすらぎ効果を有する香料が得られ、状況変化への
適応能力の強化、生理心理学的恒常性の維持機能向上に
供することができる。As described above, according to the present invention, a fragrance having an awakening effect and a fragrance having a soothing effect can be obtained, which can be used to strengthen the ability to adapt to changes in circumstances and improve the function of maintaining physiological and psychological homeostasis.
Claims (2)
,12−オキシド−13,14,15,16−テトラノ
ルバンの1種又は2種以上を0.1〜80.0重量%含
有する目覚め効果を有する香料。(1) Musk ketone, cyclopentadecanolide, 8-α
, 12-oxide-13,14,15,16-tetranorban.
1種又は2種以上を0.1〜80.0重量%含有するや
すらぎ効果を有する香料。(2) A fragrance having a soothing effect, containing 0.1 to 80.0% by weight of one or more of eucalyptol, camphor, and borneol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29797488A JPH02142720A (en) | 1988-11-24 | 1988-11-24 | Perfume |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29797488A JPH02142720A (en) | 1988-11-24 | 1988-11-24 | Perfume |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02142720A true JPH02142720A (en) | 1990-05-31 |
Family
ID=17853503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP29797488A Pending JPH02142720A (en) | 1988-11-24 | 1988-11-24 | Perfume |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02142720A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4920503A (en) * | 1972-06-19 | 1974-02-23 | ||
JPS5396339A (en) * | 1977-01-31 | 1978-08-23 | Purodeyui Kimiku E Machieeru K | Production of composition based on excellent synthetic musk |
JPS63199292A (en) * | 1987-02-13 | 1988-08-17 | 高砂香料工業株式会社 | Perfume composition and cosmetics containing the same |
JPS63199293A (en) * | 1987-02-13 | 1988-08-17 | 高砂香料工業株式会社 | Perfume composition and comsetics containing the same |
-
1988
- 1988-11-24 JP JP29797488A patent/JPH02142720A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4920503A (en) * | 1972-06-19 | 1974-02-23 | ||
JPS5396339A (en) * | 1977-01-31 | 1978-08-23 | Purodeyui Kimiku E Machieeru K | Production of composition based on excellent synthetic musk |
JPS63199292A (en) * | 1987-02-13 | 1988-08-17 | 高砂香料工業株式会社 | Perfume composition and cosmetics containing the same |
JPS63199293A (en) * | 1987-02-13 | 1988-08-17 | 高砂香料工業株式会社 | Perfume composition and comsetics containing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Grosser et al. | Behavioral and electrophysiological effects of androstadienone, a human pheromone | |
DE60025233T2 (en) | METHOD OF TREATING PEOPLE USING BODY CARE AGENTS | |
US7824715B2 (en) | Perfume compositions | |
Bensafi et al. | Sex-steroid derived compounds induce sex-specific effects on autonomic nervous system function in humans. | |
Adolph et al. | Context counts! Social anxiety modulates the processing of fearful faces in the context of chemosensory anxiety signals | |
AU2018264809B2 (en) | Novel fragrance compositions and products with mood enhancing effects | |
US20090018212A1 (en) | Methods of relieving stress | |
US20040033279A1 (en) | Process for effecting the relaxation of muscles of a human by means of fragrance | |
Larsen | Cosmetic dermatitis due to a perfume | |
Fisher et al. | The effect of perfume “ageing” on the allergenicity of individual perfume ingredients | |
JPH02142720A (en) | Perfume | |
WO2020004182A1 (en) | Sleep-enhancing agent | |
EP2799863A1 (en) | Method to evaluate fragrance compositions | |
Pinto et al. | Analysis of the human reaction to odors using electroencephalography responses | |
KR100748019B1 (en) | Perfume composition for anti-stress effect | |
JPS63199293A (en) | Perfume composition and comsetics containing the same | |
JPH03111493A (en) | Tranquilizing essential oil and perfumes containing it | |
US20140045805A1 (en) | Fragrance Compositions and Other Compositions Which Contain Naturally Occurring Substances Found in Corals | |
Steiner | The effect of odors on human experience and behavior | |
JP2012171944A (en) | θ WAVE EXPRESSION ENHANCING AGENT | |
Zhao et al. | The Effects of Olfactory Stimulation by Tree Peony Flowers on Autonomic Nervous System, Emotional States, and Brain Electrical Activity | |
Park et al. | Psychophysiological evaluation for naturally flavored cream products | |
Stürmer et al. | A psychophysiological approach to substantiate efficacy of bath additives | |
WO2012176438A1 (en) | Sedative agent for vaporization and inhalation, and sedative perfume composition containing same | |
Park et al. | Sleep Quality and Skin-Lightening Effects of White Mother Chrysanthemum Aroma |